Preimplantation genetic testing for Neurofibromatosis type 1: more than 20 years of clinical experience

Vivian Vernimmen*, Aimée D C Paulussen, Jos C F M Dreesen, Ron J van Golde, Masoud Zamani Esteki, Edith Coonen, Marianne L van Buul-van Zwet, Irene Homminga, Alwin A H A Derijck, Lloyd Brandts, Constance T R M Stumpel, Christine E M de Die-Smulders

*Bijbehorende auteur voor dit werk

    OnderzoeksoutputAcademicpeer review

    2 Citaten (Scopus)
    33 Downloads (Pure)


    Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder that affects the skin and the nervous system. The condition is completely penetrant with extreme clinical variability, resulting in unpredictable manifestations in affected offspring, complicating reproductive decision-making. One of the reproductive options to prevent the birth of affected offspring is preimplantation genetic testing (PGT). We performed a retrospective review of the medical files of all couples (n = 140) referred to the Dutch PGT expert center with the indication NF1 between January 1997 and January 2020. Of the couples considering PGT, 43 opted out and 15 were not eligible because of failure to identify the underlying genetic defect or unmet criteria for in vitro fertilization (IVF) treatment. The remaining 82 couples proceeded with PGT. Fertility assessment prior to IVF treatment showed a higher percentage of male infertility in males affected with NF1 compared to the partners of affected females. Cardiac evaluations in women with NF1 showed no contraindications for IVF treatment or pregnancy. For 67 couples, 143 PGT cycles were performed. Complications of IVF treatment were not more prevalent in affected females compared to partners of affected males. The transfer of 174 (out of 295) unaffected embryos led to 42 ongoing pregnancies with a pregnancy rate of 24.1% per embryo transfer. There are no documented cases of misdiagnosis following PGT in this cohort. With these results, we aim to provide an overview of PGT for NF1 with regard to success rate and safety, to optimize reproductive counseling and PGT treatment for NF1 patients.

    Originele taal-2English
    Pagina's (van-tot)918-924
    Aantal pagina's7
    TijdschriftEuropean journal of human genetics : EJHG
    Nummer van het tijdschrift8
    StatusPublished - 1-aug.-2023

    Citeer dit